Evidence map›Paper›PMID 33044112›Full record

ArticleAutophagy2021

SSH1 impedes SQSTM1/p62 flux and MAPT/Tau clearance independent of CFL (cofilin) activation.

Cenxiao Fang, Jung-A A Woo, Tian Liu, Xingyu Zhao, Sara Cazzaro, Yan Yan, Jenet Matlack, Teresa Kee, Patrick LePochat, David E Kang

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Ubiquitin-specific peptidase-19 links TDP-43 aggregation to ER stress.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Proximity labeling reveals dynamic changes in the SQSTM1 protein network.bioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Slingshot homolog-1-mediated Nrf2 sequestration tips the balance from neuroprotection to neurodegeneration in Alzheimer's disease.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
  9. Article
  10. Frontiers in immunology · 2022
    Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Cenxiao FangUSF Health Byrd Institute & Alzheimer Center, Tampa, FL, USA.
Jung-A A WooUSF Health Byrd Institute & Alzheimer Center, Tampa, FL, USA.
Tian LiuUSF Health Byrd Institute & Alzheimer Center, Tampa, FL, USA.
Xingyu ZhaoUSF Health Byrd Institute & Alzheimer Center, Tampa, FL, USA.
Sara CazzaroUSF Health Byrd Institute & Alzheimer Center, Tampa, FL, USA.
Yan YanUSF Health Byrd Institute & Alzheimer Center, Tampa, FL, USA.
Jenet MatlackUSF Health Byrd Institute & Alzheimer Center, Tampa, FL, USA.
Teresa KeeUSF Health Byrd Institute & Alzheimer Center, Tampa, FL, USA.
Patrick LePochatUSF Health Byrd Institute & Alzheimer Center, Tampa, FL, USA.
David E KangUSF Health Byrd Institute & Alzheimer Center, Tampa, FL, USA.
University of South Florida · USUSF Health Byrd Alzheimer's Institute · US

Funding

The Hsp90 cochaperone FKBP51 regulates tau structure and functionR01NS073899 · NINDS · UNIVERSITY OF SOUTH FLORIDA · PI Laura J Blair · 2011 to 2026
$6.9M
Novel role of β-arrestins in TauopathyR01AG059721 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI WOO, JUNGA "ALEXA" · 2019 to 2023
$1.9M
Role of the Slingshot-1 pathway in APP and Tau pathogenesisRF1AG053060 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI KANG, DAVID E · 2017 to 2017
$1.9M
Molecular Intermediates and Regulation of the Abeta-Tau Pathogenic CascadeI01BX002478 · VA · JAMES A. HALEY VA MEDICAL CENTER · PI KANG, DAVID E · 2015 to 2019
–
Divergent roles of Slingshot-1 in tauopathyI01BX004680 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI KANG, DAVID E · 2021 to 2024
–
BLRD VA I01 BX002478BLRD VA I01 BX004680NIA NIH HHS R01 AG059721NIA NIH HHS RF1 AG053060NINDS NIH HHS R01 NS073899
6 · The paper itself

Abstract

Accumulation of toxic protein assemblies and damaged mitochondria are key features of neurodegenerative diseases, which arise in large part from clearance defects in the Macroautophagy/autophagy-lysosome system. The autophagy cargo receptor SQSTM1/p62 plays a major role in the clearance of ubiquitinated cargo through Ser403 phosphorylation by multiple kinases. However, no phosphatase is known to physiologically dephosphorylate SQSTM1 on this activating residue. RNAi-mediated knockdown and overexpression experiments using genetically encoded fluorescent reporters and defined mutant constructs in cell lines, primary neurons, and brains show that SSH1, the canonical CFL (cofilin) phosphatase, mediates the dephosphorylation of phospho-Ser403-SQSTM1, thereby impairing SQSTM1 flux and phospho-MAPT/tau clearance. The inhibitory action of SSH1 on SQSTM1 is fully dependent on SQSTM1 Ser403 phosphorylation status and is separable from SSH1-mediated CFL activation. These findings reveal a unique action of SSH1 on SQSTM1 independent of CFL and implicate an inhibitory role of SSH1 in SQSTM1-mediated clearance of autophagic cargo, including phospho-MAPT/tau.

Indexed as

Actin Depolymerizing FactorsAutophagyLysosomesMacroautophagySequestosome-1 ProteinActin Depolymerizing FactorsSequestosome-1 ProteinAutophagyCFL (cofilin)MAP1LC3/LC3MAPT/taumitochondriaSQSTM1/p62SSH1tauopathyubiquitin

Identifiers

PMID33044112
PMCPMC8496729
OpenAlexW3092463416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.